Access community-based treatments for coronavirus (COVID-19)
, the COVID-19 Antivirals and Therapeutics Taskforce closed on 31 March 2023.The taskforce worked with NHS England (NHSE) and devolved administrations to ensure access to community-based treatments for coronavirus (COVID-19) for UK patients.
The arrangements for accessing treatments described on this page are therefore subject to change in spring and summer 2023.Find the most up to date information on available and how to access them on the NHS website.Since December 2021, non-hospitalised patients have accessed treatments for coronavirus (COVID-19) through the following ways:The PANORAMIC national study is run by the University of Oxford.
It is investigating groups of people that will benefit most from COVID-19 antiviral treatments. Eligible participants are recruited to the study through participating GP practices.High-risk patients with a positive COVID-19 test result are contacted by a clinician from a CMDU to discuss whether they are suitable for treatments.
The clinician is responsible for assessing and deciding which treatment option is most appropriate, taking into account any existing conditions of the patients.This patient pathway is subject to change in 2023.
Read more on gov.uk
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|
